Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

Presentation Cell Therapy 2014

Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine?

Presenter: Thomas J. Povsic

January 23, 2014

Presentation Cell Therapy 2014

Clinical Trials in Peripheral Arterial Disease

Presenter: Keith L. March

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation Cell Therapy 2014

PERFECT-Phase III Clinical TrialKey Study Elements

Presenter: Gustav Steinhoff

January 22, 2014

Presentation Cell Therapy 2014

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

Presenter: Joseph C. Wu

January 22, 2014

Presentation Cell Therapy 2014

12 months CMR and long-term clinical results of the Swiss AMI Study

Presenter: Daniel S?rder

January 22, 2014

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

Presentation Cell Therapy 2013

NIH Clinical Trial Research Network

Presenter: Timothy D. Henry

January 24, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

News Conference News Cell Therapy 2013

G-CSF Shows Positive Safety, Efficacy Signals After STEMI in Preliminary Studies

January 23, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

Presentation Cell Therapy 2012

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

Presenter: Stephen G. Ellis

January 26, 2012

Presentation Cell Therapy 2012

NIH Clinical Trial Research Network

Presenter: Jay H. Traverse

January 26, 2012

Presentation Cell Therapy 2012

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Timothy D. Henry

January 25, 2012

Advertisement

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine?

Clinical Trials in Peripheral Arterial Disease

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

PERFECT-Phase III Clinical TrialKey Study Elements

Future of Clinical Trials: Patient-Specific Stem Cells in a Dish

12 months CMR and long-term clinical results of the Swiss AMI Study

Small Heart Failure Studies Show Positive Trends for Cell Therapy

NIH Clinical Trial Research Network

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

G-CSF Shows Positive Safety, Efficacy Signals After STEMI in Preliminary Studies

BMAC for CLI: Status of a Phase 3 Trial

IMPACT Clinical Trial Program: Findings and Strategic Update

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Expedited Cell Therapy After STEMI Shows Promise

Correlation of Early Surrogate and Late Clinical Outcomes in Randomized Controlled Studies of Stem Cell Therapy for Acute MI – Implications for Endpoint Selection

NIH Clinical Trial Research Network

IMPACT Clinical Trial Program: Findings and Strategic Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content